VISITAS RECIENTES

AUTISMO TEA PDF

AUTISMO TEA PDF
TRASTORNO ESPECTRO AUTISMO y URGENCIAS PDF

We Support The Free Share of the Medical Information

Enlaces PDF por Temas

Nota Importante

Aunque pueda contener afirmaciones, datos o apuntes procedentes de instituciones o profesionales sanitarios, la información contenida en el blog EMS Solutions International está editada y elaborada por profesionales de la salud. Recomendamos al lector que cualquier duda relacionada con la salud sea consultada con un profesional del ámbito sanitario. by Dr. Ramon REYES, MD

Niveles de Alerta Antiterrorista en España. Nivel Actual 4 de 5.

Niveles de Alerta Antiterrorista en España. Nivel Actual 4 de 5.
Fuente Ministerio de Interior de España

jueves, 28 de septiembre de 2023

Prehospital Fluid Management in Hemorrhagic Shock. "A survey of EMS medical direction practice" by JEMS.com



Prehospital Fluid Management in Hemorrhagic Shock by jems.com
Prehospital Fluid Management in Hemorrhagic Shock.
"A survey of EMS medical direction practice"

Hemorrhagic shock is a clinical state in which severe blood loss causes insufficient cellular oxygen delivery, leading to organ failure and, ultimately, death.1 Annually, over 60,000 deaths in the United States and some 1.9 million worldwide are due to hemorrhagic shock, with some 1.5 million of these cases associated with trauma.2,10

IV fluid resuscitation has become a staple of prehospital management of hemorrhagic shock. However, subsequent studies from both laboratory control models and post-transport patient outcomes have questioned this practice, suggesting that permissive hypotension (i.e., systolic blood pressure [SBP] of 80 mmHg or below in adults) or resuscitation with blood products leads to improved patient outcomes and survival.

It’s unclear whether, despite this evolving body of work, these recommendations have been broadly adopted by civilian EMS practices in the prehospital setting.

The authors surveyed the medical directors of many large EMS systems to determine whether the practice of permissive hypotension or the administration of prehospital blood products has been more widely adopted.

Methods
A survey was sent to the EMS medical directors of many large EMS systems (the “Eagles Coalition”) who were asked two questions: 1) Whether their system used blood or blood products during the prehospital resuscitation phase of hemorrhagic shock management; and 2) The blood pressure targets, if relevant, associated with their hemorrhagic shock resuscitation protocol.

For categorization of results, we defined the maintenance of SBP of 80 mmHg or less—or mean arterial pressure (MAP) of 45–50 mmHg or less—as “permissive hypotension.”

We excluded head trauma or pediatric resuscitation protocols, interpreting only traumatic hemorrhagic shock—both penetrating and blunt force—survey results.

Results
Of the polled group, 22 members responded to the survey. Resuscitation protocols weren’t consistent within the group, with four (4) general methods reported as resuscitation targets. 61% of respondents administer fluids to a predetermined target SBP, 5% to a target MAP, 5% to a palpable radial pulse, and 29% allow permissive hypotension.

Within the SBP group, SBP targets range from a low of 70 mmHg to a high of 100 mmHg, with the majority of respondents choosing a SBP resuscitation target of 90 mmHg.

With respect to fluid administration, 14% of the respondent group use no fluid resuscitation (i.e., employing strict permissive hypotension), 81% use crystalloid product (i.e., defined as normal saline or lactated ringers solution), and 5% use blood products. Results are summarized in Figures 1, 2 and 3 below.

Discussion
Our study indicates that a generally accepted prehospital protocol with respect to the management of hemorrhagic shock remains the subject of considerable debate. Data continue to suggest that limiting the use of crystalloid is a more optimal strategy for management of hemorrhagic shock, preserving normothermia and preventing excessive dilution of both red blood cell volume and clotting factors.13–16,19–23

Additionally, it’s apparent from clinical experience gained both in civilian centers and in military theaters that the administration of blood and blood products to patients in hemorrhagic shock is associated with improved patient outcomes.13,14

Moreover, 10-year trends of crystalloid administration secondary to hemorrhagic shock have been in decline, and civilian EMS system administration of blood and blood products has been determined as a feasible prehospital practice.17,18

Still, it appears that the practice has not been widely adopted by EMS organizations, as only 5% of respondents in our survey employed the administration of blood and blood products.



The hesitation to provide for the administration of blood and blood products in EMS systems to patients with hemorrhagic shock is understandable given the complexity of the issues involved: Storage, cost, handling (including transport and refrigeration where necessary) and expiration dates.

Nonetheless, advancing evidence suggests that blood and blood product administration is superior to crystalloid in the management of hemorrhagic shock.

This study has several limitations, including the stratification of resuscitation protocols as regards to hemorrhagic shock resuscitation in the presence and absence of head injury, and it doesn’t explore the resuscitative management of pediatric patients. Still, these data provide perspective on the current practice environment on this clinical issue among large EMS systems.

Conclusion
Despite the growing body of evidence supporting the use of blood and blood products in the prehospital resuscitation of patients with hemorrhagic shock, few EMS systems employ these treatments at this time.

The complexity of issues involved with the administration of blood and blood products to these patients bears additional study, which may better inform and influence practice change in the prehospital setting.

References

1. Savasta S, Marchi A, Bianchi E, et al. Hemorrhagic shock and encephalopathy: Diagnostic criteria. Am J Dis Child. 1992;146(3):279.

2. Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378(4):370–379.

3. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105–1109.

4. Barkana Y, Stein M, Maor R, et al. Prehospital blood transfusion in prolonged evacuation. J Trauma. 1999;46(1):176–180.

5. Stern SA. Low-volume fluid resuscitation for presumed hemorrhagic shock: Helpful or harmful? Curr Opin Crit Care. 2001;7(6):422–430.

6. Gou DY1, Zhu YF, Jin Y, et al. Spontaneous diuresis and negative fluid balance predicting recovery and survival in patients with trauma-hemorragic shock. Chin J Traumatol. 2003;6(6):382–384.

7. Mauriz JL, Martín Renedo J, Barrio JP, et al. [Experimental models on hemorrhagic shock.] Nutr Hosp. 2007;22(2):190–198.

8. Dawes R, Thomas Go. Battlefield resuscitation. Curr Opin Crit Care. 2009;15(6):527–535.

9. Durusu M, Eryilmaz M, Oztürk G, et al. Comparison of permissive hypotensive resuscitation, low-volume fluid resuscitation, and aggressive fluid resuscitation therapy approaches in an experimental uncontrolled hemorrhagic shock model. Ulus Travma Acil Cerrahi Derg. 2010;16(3):191–197.

10. Curry N, Hopewell S, Dorée C, et al. The acute management of trauma hemorrhage: A systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92.

11. Haut ER, Kalish BT, Cotton BA, etc. Prehospital intravenous fluid administration is associated with higher mortality in trauma patients: A National Trauma Data Bank analysis. Ann Surg. 2011;253(2):371–377.

12. Bhangu A, Nepogodiev D, Doughty H, et al. Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury. 2013;44(12):1693–1699.

13. O'Reilly DJ, Morrison JJ, Jansen JO, et al. Prehospital blood transfusion in the en route management of severe combat trauma: a matched cohort study. J Trauma Acute Care Surg. 2014;77(3 Suppl 2):S114–S120.

14. Holcomb JB, Donathan DP, Cotton BA, et al. Prehospital transfusion of plasma and red blood cells in trauma patients. Prehosp Emerg Care. 2015;19(1):1–9.

15. Copotoiu R, Cinca E, Collange O, et al. [Pathophysiology of hemorragic shock]. Transfus Clin Biol. 2016;3(4):222–228.

16. Driessen A, Fröhlich M, Schäfer N, et al. Prehospital volume resuscitation--Did evidence defeat the crystalloid dogma? An analysis of the TraumaRegister DGU(R) 2002–2012. Scand J Trauma Resusc Emerg Med. 2016;24: 42.

17. Harada MY, Ko A, Barmparas G, et al. 10-year trend in crystalloid resuscitation: Reduced volume and lower mortality. Int J Surg. 2017;38:78–82.

18. Bodnar D, Rashford S, Williams S, et al. The feasibility of civilian prehospital trauma teams carrying and administering packed red blood cells. Emerg Med J. 2014;31(2):93–95.

19. Kheirabadi BS, Miranda N, Terrazas IB, et al. Does small-volume resuscitation with crystalloids or colloids influence hemostasis and survival of rabbits subjected to lethal uncontrolled hemorrhage? J Trauma Acute Care Surg. 2017;82(1):156–164.

20. László I, Demeter G, Öveges N, et al. Volume-replacement ratio for crystalloids and colloids during bleeding and resuscitation: an animal experiment. Intensive Care Med Exp. 2017;5(1):52.

21. Maegele M, Fröhlich M, Caspers, et al. Volume replacement during trauma resuscitation: a brief synopsis of current guidelines and recommendations. Eur J Trauma Emerg Surg. 2017;43(4):439–443.

22. Zhao G, Wu W, Feng QM, et al. Evaluation of the clinical effect of small-volume resuscitation on uncontrolled hemorrhagic shock in emergency. Ther Clin Risk Manag. 2017;13:387–392.

23. Holcomb J. Combative behaviors: Translocating military medicine research into civilian lifesaving [presentation]. Gathering of Eagles: The EMS State of the Science Conference: Dallas, 2018.

By
Raymond L. Fowler, MD, FACEP, FAEMS
Raymond L. Fowler, MD, FACEP, FAEMS, is the James M. Atkins MD Professor of EMS and chief of the Division of EMS at the University of Texas Southwestern Medical Center in Dallas. He's been involved in EMS as a leading educator, author, medical director, and political advocate for more than four decades, and is a member of the JEMS Editorial Board.
Reed Macy, BA
Reed Macy, BA, is a fourth-year medical student at the University of Texas Southwestern Medical Center and an upcoming emergency medicine resident.

Gil Salazar, MD, FACEP
Gil Salazar, MD, FACEP, is the director of the section on EMS education at the University of Texas Southwestern Medical Center.

Hunter Pyle, BBA
Hunter Pyle, BBA, is a first-year medical student at the University of Texas Southwestern Medical Center.


Existen diversos tipos de shock y entre ellos, encontramos el shock hipovolémico que se divide en shock hemorrágico y no hemorrágico. Puedes ver la clasificación de los tipos de shock aquí.

El shock hemorrágico se caracteriza por:
Pérdida masiva extravascular de sangre, lo que provoca una disminución del volumen sanguíneo.
La hemorragia puede ser tanto interna como externa.
Suele ser el tipo de shock más frecuente, ya que puede darse en intervenciones quirúrgicas, traumatismos, hemorragias obstétricas o digestivas.

Durante su fase inicial, la gravedad del shock hemorrágico está relacionada con el volumen de sangre perdido. El American College of Surgeons Advanced Trauma Life Support Manual define cuatro estadios de gravedad en el shock (I-IV) . Por ello, he realizado una infografía lo más visual posible, para que puedas entender y memorizar más fácilmente esta clasificación.


Clasificación American College of Surgeons
Fuentes:
Ronald D. Miller. (2016). Manejo de la sangre del paciente: terapia transfusional.
En Miller Anestesia(1830-1867). España: Elsevier.
Shock hemorrágico. Anestesia-Reanimación, 2010-01-01, Volumen 36, Número 3, Páginas 1-22. 2010 Elsevier Masson SAS
[Última actualización 27/02/2018]




Todas nuestras publicaciones sobre Covid-19 en el enlace


AVISO IMPORTANTE A NUESTROS USUARIOS


Este Blog va dirigido a profesionales de la salud y publico en general EMS Solutions International garantiza, en la medida en que puede hacerlo, que los contenidos recomendados y comentados en el portal, lo son por profesionales de la salud. Del mismo modo, los comentarios y valoraciones que cada elemento de información recibe por el resto de usuarios registrados –profesionales y no profesionales-, garantiza la idoneidad y pertinencia de cada contenido.


Es pues, la propia comunidad de usuarios quien certifica la fiabilidad de cada uno de los elementos de información, a través de una tarea continua de refinamiento y valoración por parte de los usuarios.

Si usted encuentra información que considera erronea, le invitamos a hacer efectivo su registro para poder avisar al resto de usuarios y contribuir a la mejora de dicha información.

El objetivo del proyecto es proporcionar información sanitaria de calidad a los individuos, de forma que dicha educación repercuta positivamente en su estado de salud y el de su entorno. De ningún modo los contenidos recomendados en EMS Solutions International están destinados a reemplazar una consulta reglada con un profesional de la salud.

miércoles, 27 de septiembre de 2023

Nerve Block Shows Promise for Long COVID-Related Olfactory or Gustatory Dysfunction Patients report improved sense of smell and taste. El bloqueo nervioso es prometedor para la disfunción olfativa o gustativa prolongada relacionada con la COVID Los pacientes informan una mejora en el sentido del olfato y el gusto.

 

Loss of smell and taste are among the most common symptoms after COVID-19 infection. While a survey published in the International Forum of Allergy & Rhinology indicates that nearly half of those who report olfactory dysfunction regain their sense of smell within a month, the problem can linger.

“I am still seeing patients who had the initial infection in 2020, and for the last three years they have been silently suffering from altered smell and/or taste,” says Christina Shin, MD, a Cleveland Clinic pain management physician.

Olfactory and gustatory training is the first-line recommended treatment. But when it fails, patients are increasingly turning to Dr. Shin and other pain management physicians for a novel treatment – stellate ganglion block (SGB).

Subjective evidence of symptom improvement

In the past year, Dr. Shin has administered the stellate ganglion block with ultrasound imaging guidance to approximately 40 patients. Her first patient arrived to the initial consultation with a case series published by Luke Liu, MD, a pain medicine specialist in Anchorage, Alaska, who pioneered the use of SGB to reduce symptoms in patients with long COVID.

“I don’t tout this as a cure,” says Dr. Shin. “In review of my clinical experience caring for patients, I would conservatively estimate that at least 50% of patients achieve at least 50% improvement. Of course, further research is needed.”

One year after her stellate ganglion block, Dr. Shin’s first patient reports a 90% improvement. That has had a tremendous impact on her quality of life, given that for two years food tasted rancid.

“She is back to work, spending time with family and enjoying her social life,” says Dr. Shin. “She is also off anti-depressants.”

SGB and long COVID theories

Stellate ganglion block targets the sympathetic system, specifically the face and upper extremities. Indications include complex regional pain syndrome of the head and upper limbs, postherpetic neuralgia, hyperhidrosis, chronic post-surgical pain, peripheral vascular disease, and orofacial pain.

It’s unclear how SGB works for patients with loss of smell and taste – or even what causes long COVID – but experts posit several theories.

First, long COVID: One theory is that the virus directly invades tissues in the lungs, nasal mucosa and brain, causing destruction. Another is that the immune system becomes hyperactive in response to the infection, leaving patients in a state of persistent inflammation. A third hypothesis suggests that the sympathetic system is in overdrive, persistently active, leading to fatigue and other long COVID symptoms.

“The fact that the stellate ganglion block is working for some patients tells us that at least for those patients, it may be related to the persistent, overactive sympathetic system,” says Dr. Shin. “So, when we temporarily stop activity at that bundle of nerves and patients get better, perhaps we are interrupting this overactivity and allowing their bodies to reset and get back to a more normal sympathetic balance.”

Another possibility is that the stellate ganglion and the sympathetic system are closely connected to the immune system.

“The thought is that by modulating or blocking the sympathetic system, we somehow regulate the immune system,” says Dr. Shin.

Finally, when the stellate ganglion is blocked, blood flow increases to that side of the body and the brain. That may improve signaling of existing neurons involved in the processing of smell and taste.



Indications, contraindications and risks

Jijun Xu, MD, PhD, who holds joint appointments in Cleveland Clinic’s Department of Pain Management and the Department of Inflammation and Immunity at Lerner Research Institute, also has administered stellate ganglion blocks. Although SGB is a well-defined treatment in pain management, he stresses that its use for olfactory disorder associated with COVID-19 is still experimental and not effective for all patients. However, he considers it a viable option for some patients.

“When SGB works, it seems to work effectively,” says Dr. Xu. “Considering its low risk profile and potential benefit, SGB is worth trying for these patients as it may significantly help improve a patient’s quality of life. More importantly, some patients lose their ability to smell gas in heating appliances or cooking equipment, which could be dangerous or even life-threatening. To bring their smell back is therefore of the utmost importance.”

Patients may require follow-up treatments similar to SGB use for pain management.

At Cleveland Clinic’s reCOVer Clinic for long COVID patients, Dr. Shin is collaborating with ENT specialists to outline indications and develop a pathway for patients with loss of smell and taste who may benefit from SGB. She currently evaluates patients who have had a confirmed COVID-19 diagnosis and have been diagnosed with COVID-related smell and taste disorder. She also encourages patients to see an ENT specialist first to make sure there isn’t an underlying issue.

“If you have a primary smell and taste disorder from trauma, sinusitis or other conditions, the nerve block may not change that,” says Dr. Shin.

In addition, contraindications for stellate ganglion block include glaucoma, coagulopathy, recent myocardial infarction, severe pulmonary disease, pre-existing counter lateral nerve palsy and cardiac conduction block. Potential risks of the procedure include bleeding and infection, as well as puncture of nearby structures, such as the trachea, esophagus, carotid artery and internal jugular.

“Overall, it’s a safe procedure, and we have found ways to improve the safety over the last several years, especially when it is image-guided, such as with ultrasound,” says Dr. Shin.

Advice for physicians

Dr. Shin suggests that physicians caring for patients with COVID-related olfactory disorder take the following steps:

Send patients to an ENT physician to confirm the diagnosis and rule out other conditions.

Consider olfactory training as the first-line therapy.

Refer the patient to a trained interventional pain management physician for an assessment for SGB.

“I am cautiously optimistic about this experimental treatment,” says Dr. Shin. “In the right person – someone who doesn’t have contraindications and the benefit outweighs the risk – the stellate ganglion block may be utilized for COVID-related smell and taste disorders.”

May. 17, 2023 / Pain Management / Innovation

https://consultqd.clevelandclinic.org/nerve-block-shows-promise-for-long-covid-related-olfactory-or-gustatory-dysfunction/


Por favor compartir nuestras REDES SOCIALES @DrRamonReyesMD, así podremos llegar a mas personas y estos se beneficiarán de la disponibilidad de estos documentos, pdf, e-book, gratuitos y legales..


Grupo Biblioteca/PDFs gratis en Facebook

Facebook




Pinterest

Twitter

Blog

Gracias a todos el Canal somos mas de  1000 participantes en WhatsApp. Recordar este es un canal y sirve de enlace para entrar a los tres grupos; TACMED, TRAUMA y Científico. ahí es que se puede interactuar y publicar. Si le molestan las notificaciones, solo tiene que silenciarlas y así se beneficia de la informacion y la puede revisar cuando usted así lo disponga sin el molestoso sonido de dichas actualizaciones, Gracias a todos Dr. Ramon Reyes, MD Enlace al 




Enlace a Científico https://chat.whatsapp.com/IK9fNJbihS7AT6O4YMc3Vw en WhatsApp 

TELEGRAM Emergencias https://t.me/+sF_-DycbQfI0YzJk  

TELEGRAM TACMED https://t.me/CIAMTO